Vivos Therapeutics (NASDAQ: VVOS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vivos Therapeutics (NASDAQ: VVOS) through any online brokerage.
There are no as such competitors for Vivos Therapeutics.
The latest price target for Vivos Therapeutics (NASDAQ: VVOS) was reported by Roth Capital on Friday, August 13, 2021. The analyst firm set a price target for 10.00 expecting VVOS to rise to within 12 months (a possible 604.23% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $1.42 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Vivos Therapeutics.
Vivos Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Vivos Therapeutics.
Vivos Therapeutics is in the Healthcare sector and Medical Devices industry. They are listed on the NASDAQ.